We are live on ! Find out more
ORTX

Orchard Therapeutics plc American Depositary Shares
ORTX

Delisted

ORTX was delisted on the 23rd of January, 2024.

Back to rankings

77 hedge funds and large institutions have $247M invested in Orchard Therapeutics plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 16

50% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 10

7% more funds holding

Funds holding: 72 → 77 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less capital invested

Capital invested by funds: $265M → $247M (-$17.8M)

78% less call options, than puts

Call options by funds: $237K | Put options by funds: $1.05M

Holders
77
Holders Change
+5
Holders Change %
+6.94%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
32
Reduced
16
Closed
10
Calls
$237K
Puts
$1.05M
Net Calls
-$818K
Net Calls Change
-$627K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$3.64M
2
WP
Woodline Partners
California
+$2.55M
3
Artisan Partners
Artisan Partners
Wisconsin
+$1.68M
4
PIM
Platinum Investment Management
Australia
+$1.18M
5
Goldman Sachs
Goldman Sachs
New York
+$1.04M

Top Sellers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$11.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.8M
3
CC
Casdin Capital
New York
-$7.69M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$5.19M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
MOACM
26
Mutual of America Capital Management
New York
$1.13M +$422K +9,427 +57%
CAM
27
Cormorant Asset Management
Massachusetts
$1.11M – – –
State Street
28
State Street
Massachusetts
$857K +$120K +2,677 +16%
Renaissance Technologies
29
Renaissance Technologies
New York
$748K +$598K +13,353 +338%
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$746K -$16.1K -360 -2%
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$725K +$654K +14,600 +668%
Millennium Management
32
Millennium Management
New York
$644K -$958K -21,384 -59%
Rafferty Asset Management
33
Rafferty Asset Management
New York
$416K +$431K +9,631 New
Group One Trading
34
Group One Trading
Illinois
$408K +$411K +9,177 +3,463%
Two Sigma Investments
35
Two Sigma Investments
New York
$406K +$421K +9,393 New
Victory Capital Management
36
Victory Capital Management
Texas
$368K -$26.8K -599 -7%
Squarepoint
37
Squarepoint
New York
$351K +$364K +8,118 New
Ameriprise
38
Ameriprise
Minnesota
$347K -$12.4K -276 -3%
VEA
39
Virtus ETF Advisers
New York
$280K +$110K +2,455 +61%
Legal & General Group
40
Legal & General Group
United Kingdom
$246K +$141K +3,156 +123%
Mitsubishi UFJ Asset Management
41
Mitsubishi UFJ Asset Management
Japan
$242K +$158K +3,520 +169%
Citadel Advisors
42
Citadel Advisors
Florida
$199K +$119K +2,655 +136%
SEI Investments
43
SEI Investments
Pennsylvania
$185K +$31.8K +710 +20%
Northern Trust
44
Northern Trust
Illinois
$152K -$4.66K -104 -3%
AC
45
Athanor Capital
New York
$148K +$154K +3,430 New
FA
46
Forefront Analytics
Pennsylvania
$139K +$7.7K +172 +6%
WCM
47
Weld Capital Management
New York
$114K +$24.9K +556 +27%
BFM
48
Boothbay Fund Management
New York
$114K +$119K +2,646 New
TD Asset Management
49
TD Asset Management
Ontario, Canada
$110K -$145K -3,227 -56%
BWM
50
Bulltick Wealth Management
Florida
$94.5K +$98K +2,188 New
1
2
3 4

ORTX Hedge Fund Activity: Q4 2020 in Review

77 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q4 2020, worth a combined $247M — down 6.7% from $265M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ORTX positions and 10 closed out — a net gain of 5 holders — while 32 added to existing stakes and 16 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $3.64M. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $11.3M sold.

  • 77 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q4 2020, up from 72 in Q3 2020.
  • Funds reported $247M of Orchard Therapeutics plc American Depositary Shares stock for Q4 2020, down 6.7% quarter-over-quarter.
  • 15 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q4 2020 and 10 closed out, a net change of +5 holders.
  • The largest Orchard Therapeutics plc American Depositary Shares buyer in Q4 2020 was JP Morgan Chase, an estimated $3.64M added.
  • The largest Orchard Therapeutics plc American Depositary Shares seller in Q4 2020 was Baillie Gifford & Co, an estimated $11.3M sold.

Based on aggregated 13F filings for Q4 2020.